Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.
about
Early versus delayed postoperative radiotherapy for treatment of low-grade gliomasMultimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR ImagingSeizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic reviewTumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor TherapyImmunotherapy response assessment in neuro-oncology: a report of the RANO working groupSeizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewNew concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach.Recommendations for imaging tumor response in neurofibromatosis clinical trials.Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade glioma.Functional imaging in adult and paediatric brain tumours.Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.Impact of MRI head placement on glioma response assessment.Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant GliomaGlioblastoma biomarkers from bench to bedside: advances and challenges.Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma.Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions.Current treatment of low grade gliomasInduction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.Conclusions and future directions for the REiNS International Collaboration.Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424The association between cognitive functioning and health-related quality of life in low-grade glioma patients.Evaluation of RANO response criteria compared to clinician evaluation in WHO grade III anaplastic astrocytoma: implications for clinical trial reporting and patterns of failure.Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study.Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.Imaging of gliomas at 1.5 and 3 Tesla - A comparative study.Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas.Relationship between exercise behavior, cardiorespiratory fitness, and cognitive function in early breast cancer patients treated with doxorubicin-containing chemotherapy: a pilot study.Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials.CNS Anticancer Drug Discovery and Development Conference White Paper.Early Detection of Malignant Transformation in Resected WHO II Low-Grade Glioma Using Diffusion Tensor-Derived Quantitative Measures.Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors.Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma.Controversies in management of low-grade gliomas in light of new data from clinical trials.
P2860
Q24186964-04A72175-C949-4071-AFC6-A775CFCB0868Q26796223-25C325DB-EDFC-4583-AB3F-01B4E2D1B2F3Q27027730-35130744-2BF6-4F28-83D2-4AD8C5E5351FQ28069398-C723F997-B192-4E5A-A1E0-55E00AD11702Q28083009-6B06304E-EAB8-44C7-9E79-DDD03734ED7EQ30275879-D12ACE63-C93B-4C20-8FFD-10646BAB58A4Q30356126-7A235585-9244-44EB-9784-6333F70B6DD3Q30365386-30FF5085-F21F-4337-9837-F0295184B4E3Q30425757-5A3B5849-C244-43C1-A6A5-5BA511B28B45Q30458648-BBB48E8E-EA99-460D-9E8F-8D08708ACBA3Q30577397-C41DC05E-5795-4C1A-8AE0-E30D029A8B93Q30607148-BDB03F3A-735A-49E3-B92C-420DA7C5F004Q30967370-9899F465-75D3-4370-B5F0-4668E70451CDQ31016200-3BF987A4-0065-4594-A3FC-7CF2C525BA13Q33399939-94BFBA79-0CED-49F4-904D-B01ADD126A8FQ33438666-270ABF10-5587-4556-8701-BFC22A9F5205Q33632237-489F177B-4C01-47A5-AD7F-A35AC29CDFB1Q33816600-AE713077-10F8-4A50-9289-F31B55ACD8BBQ34103890-10669230-1F7B-4733-A6A3-E69C50A566FCQ34186787-668A8B57-CC0D-482B-8F7B-B857748905A6Q34234748-D99041E4-5EFE-4E04-A9D9-6D43C4F0DA8AQ34604438-7928B6D8-9786-4A14-B4A4-AD1F528014B5Q34830708-1224CB68-9CA0-464D-A1F1-7AAE6A144591Q34979511-9818F0F8-5215-4B0A-87E7-99F336321447Q35046441-C0ED9C96-22CC-46BD-AC95-6127E5676133Q35085561-BFF92C22-961F-44DB-B120-26988A3CF9FCQ35210743-38EBFB0A-C85F-4190-8630-47DF0D76B231Q35214747-7662ADF7-2F7D-4EDB-B407-F6222C8EC88FQ35225228-B090FB70-D2A6-4F0F-95D4-0E27FC829E37Q35675842-A9F64247-23F6-49B5-BAE2-A1239B2CE6DCQ35788981-8704C1BF-BA77-4FE8-9542-D5212EFD5CE8Q35845266-4C1B8617-898B-462F-BB13-08CA46B9631EQ35972547-2B96691A-A521-4EEA-A14B-C519DA8143ECQ36068377-2E3383A8-77D3-41E9-AB77-BC8D6816CFA0Q36089590-0A1C7015-86C2-44EA-8CBF-AFFF94E2C13FQ36164058-4CEB4D45-CFB4-41AA-9033-0EDDBED0AEFDQ36210293-D3543FCE-C2A3-4761-BE61-7292A33649E0Q36250739-0C13E77E-4664-42EB-860D-E9B3109D18A9Q36250758-96639612-F82A-4A48-88A4-FA2D6D9A10D9Q36341111-99A64E14-B2B1-451B-AF45-3BCEDB7EDE2E
P2860
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Response assessment in neuro-o ...... of diffuse low-grade gliomas.
@ast
Response assessment in neuro-o ...... of diffuse low-grade gliomas.
@en
type
label
Response assessment in neuro-o ...... of diffuse low-grade gliomas.
@ast
Response assessment in neuro-o ...... of diffuse low-grade gliomas.
@en
prefLabel
Response assessment in neuro-o ...... of diffuse low-grade gliomas.
@ast
Response assessment in neuro-o ...... of diffuse low-grade gliomas.
@en
P2093
P50
P1433
P1476
Response assessment in neuro-o ...... s of diffuse low-grade gliomas
@en
P2093
A Choucair
A H Jacobs
B G Baumert
D A Reardon
D R Macdonald
M A Vogelbaum
P304
P356
10.1016/S1470-2045(11)70057-2
P577
2011-04-05T00:00:00Z